Marshfield Associates Portfolio holdings
Marshfield Associates is a long-only value investor that holds a concentrated portfolio of roughly 16 to 20 stocks and is willing to sit on cash. The firm was established in 1989 and is owned by its principals, with Christopher Niemczewski as managing principal. Its clients include pension plans, foundations, charitable organizations and high net worth individuals, served through individually managed portfolios and a mutual fund. That fund, the Marshfield Concentrated Opportunity Fund, follows the same approach as the firm's core stock strategy.
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Expeditors International
EXPD
|
+$75M |
| 2 |
UnitedHealth
UNH
|
+$44.9M |
| 3 |
Ross Stores
ROST
|
+$38.3M |
| 4 |
Strategic Education
STRA
|
+$32.6M |
| 5 |
AutoZone
AZO
|
+$30.4M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 38.21% |
| 2 | Consumer Discretionary | 37.05% |
| 3 | Healthcare | 13.07% |
| 4 | Industrials | 8.22% |
| 5 | Communication Services | 3.14% |
Similar funds
Marshfield Associates's Q3 2026 Portfolio in Review
As of Q3 2026, Marshfield Associates held 17 positions worth $3.97B, down 6.8% from $4.26B the previous quarter. Its ten largest holdings account for 80% of the portfolio.
Marshfield Associates withdrew a net $144M in Q3 2026, reducing 15 holdings. Its largest reduction was Expeditors International, cutting an estimated $75M.
By sector, the portfolio is most concentrated in Financials at 38% of assets, down from 38% a quarter earlier, followed by Consumer Discretionary and Healthcare.
Against the trend, Marshfield Associates added an estimated $210M to Nike.
- Marshfield Associates added most to Nike in Q3 2026, an estimated $210M increase.
- Marshfield Associates's biggest Q3 2026 reduction was Expeditors International, cutting an estimated $75M.
- Marshfield Associates's ten largest holdings make up 80% of its $3.97B portfolio in Q3 2026.
- Marshfield Associates opened 0 new positions and closed 0 in Q3 2026.
- Marshfield Associates's portfolio value fell 6.8% quarter-over-quarter to $3.97B.
Based on Marshfield Associates's 13F filing for Q3 2026, filed 16 Nov 2026.